表紙:世界の疼痛管理装置市場-予測(2021年~2026年)
市場調査レポート
商品コード
1023159

世界の疼痛管理装置市場-予測(2021年~2026年)

Global Pain Management Devices Market - Forecasts from 2021 to 2026

出版日: | 発行: Knowledge Sourcing Intelligence | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
世界の疼痛管理装置市場-予測(2021年~2026年)
出版日: 2021年07月08日
発行: Knowledge Sourcing Intelligence
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の疼痛管理装置市場規模は、2019年の48億3400万米ドルから2026年には100億5900万米ドルに達すると予想されており、予測期間中に11.04%の複合年間成長率で成長することが見込まれています。

痛みの治療には、薬物治療や器具を使った特定の治療法があります。悪性腫瘍の進行、筋骨格の損傷、神経障害性疼痛などによる痛みの治療に役立ちます。また、長期にわたるアヘン剤、非ステロイド系鎮静剤などの使用の危険性を減らすことができます。

悪性腫瘍人口、生活習慣病の増加、神経障害性疾患の拡大などが、世界の疼痛管理装置市場の発展を促進する主な要因です。医療サービスに対する期待や医療消費の増加も、発展を後押ししています。一方で、皮膚の過度の触感、発赤、色素沈着や、痛み緩和処方などの代替品が、発展を制限する主な要因の一部となっています。

最後に、今後数年の間に疼痛管理装置の需要が増加すると予測されることを考慮して、世界中の市場参加者は新製品の開発とそれに伴う市場シェアの拡大のために様々な戦略的行動を取っています。例えば、2020年4月には、Omron社が投薬不要の疼痛管理製品に加えて、膝用のFocus TENS Therapy装置を発売しており、これは同社の市場シェアを拡大するだけでなく、疼痛管理装置市場を大きく活性化させると期待されています。

当レポートでは世界の疼痛管理装置市場について調査分析し、市場力学、デバイス別、アプリケーション別、地域別市場分析、競合環境と分析、企業プロファイルを提供しています。

目次

第1章 イントロダクション

  • 市場の定義
  • 市場セグメンテーション

第2章 調査手法

  • 調査データ
  • 仮定

第3章 エグゼクティブサマリー

  • 調査のハイライト

第4章 市場力学

  • 市場の推進要因
  • 市場の抑制要因
  • ポーターズファイブフォース分析
    • 供給側の交渉力
    • 買い手の交渉力
    • 新規参入の脅威
    • 代替品の脅威
    • 機能における競合間の競争
  • 機能バリューチェーン分析

第5章 デバイス別世界の疼痛管理装置市場分析

  • イントロダクション
  • 電気刺激装置
  • 神経刺激装置
  • 鎮痛剤輸液ポンプ
  • 除去装置

第6章 アプリケーション別世界の疼痛管理装置市場分析

  • イントロダクション
  • 顔面および片頭痛の痛み
  • 神経因性疼痛
  • がん性疼痛
  • 筋骨格痛
  • その他

第7章 地域別世界の疼痛管理装置市場分析

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 南米
    • ブラジル
    • アルゼンチン
    • その他
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • その他
  • 中東とアフリカ
    • イスラエル
    • サウジアラビア
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • 台湾
    • タイ
    • インドネシア
    • その他

第8章 競合環境と分析

  • 主要プレーヤーと戦略分析
  • 新興プレーヤーと市場の収益性
  • 合併、買収、合意、およびコラボレーション
  • ベンダー競争力のマトリックス

第9章 企業プロファイル。

  • NeuroMetrix、Inc。
  • メドトロニック
  • ボストンサイエンティフィックコーポレーション
  • Zynex Medical
  • バイオエレクトロニクス株式企業
  • 疼痛管理技術
  • SPR治療薬
  • Becton、Dickinson、およびCompany
  • アボット
  • Nevro Corp
目次
Product Code: KSI061611753

The global pain management devices market is expected to grow at a compound annual growth rate of 11.04% over the forecast period to reach a market size of US$10.059 billion in 2026 from US$4.834 billion in 2019. Pain is an unpleasant sensory and emotional experience caused due to tissue damage or illness. It is caused because of injury and different infections like osteoarthritis, ongoing joint inflammation, diabetic neuropathy, numerous sclerosis, stomach ulcer, fibromyalgia, and malignancy. It tends to be characterized based on the term as intense pain and persistent pain. Intense pain is the unexpected beginning of pain though ongoing pain perseveres for extensive stretches. Constant pain is caused because of maturing states of bone and joints and nerve harm and injury. Pain is overseen by a specific arrangement of medications or devices to treat pain. Transcutaneous electrical nerve triggers, neuro-triggers, absence of pain mixture siphons, and radiofrequency ablators are a portion of the pain management devices. A large portion of these devices blocks the pain entryway component, to impede the section of pain signs to the mind. Radiofrequency ablators obliterate nerves by creating warmth to impede the pain signals, Similarly, neuro-trigger devices utilize gentle frequencies of current to obstruct the entry of pain signals. These devices help in treating different painful conditions like malignant growth, musculoskeletal injury, and neuropathic pain. Pain management devices help to decrease the danger of long-haul opiates, non-steroidal calming drugs, and other pain-mitigating prescriptions.

As of late there is expanded utilization of pain management devices because of ascending in maturing populace. Expansion in malignancy populace, expanding predominance of a way of life-related sickness, and expanding neuropathic messes are a portion of the key variables driving the development of the global pain management devices market. Furthermore, expanding medical services mindfulness and ascend in medical care consumption are likewise energizing the development of the worldwide pain management devices market. Be that as it may, results, for example, skin excessive touchiness, redness, and hyper-pigmentation, and accessibility of substitutes, for example, pain alleviation prescriptions are a portion of the main considerations limiting the development for worldwide pain management devices market. Lastly, taking into account the estimated increase in demand for pain management devices in the upcoming years, market players all around the globe are undertaking various strategic actions to develop new products and subsequently, increase their market share too. For instance, In April 2020, Omron launched another Focus TENS Therapy gadget for the knee to its current setup of medication-free pain management items, which is expected to not only increase the market share of the company but also boost the pain management devices market.

Growth Factors.

  • Rising prevalence of pain-inducing diseases.

The rising cancer cases are expected to further increase the demand for pain management devices over the forecast period. Besides, the high predominance of musculoskeletal problems, like joint inflammation, osteoarthritis, muscular degenerative issues, and rheumatoid joint pain, and a resultant ascent in instances of ongoing pain and failure to do routine errands, will support item interest. For example, as per the CDC, more than 54 million instances of joint inflammation were recorded in the U.S. in 2019, making it the essential justification work handicap. This has fueled the interest for pain management triggers to oversee constant pain. The incapability of oral medications is boosting patients to search for elective treatment choices, for example, pain management devices. The significant expenses related to hospitalization are additionally expected to help the pain management devices market as these significant expenses related to hospitalization have expanded the requirement for a diminished medical clinic stay and the need to move to more affordable consideration settings, in this way boosting item interest. For instance, the average hospital stay cost accounted for around USD 15,734 in 2018. Moreover, technological advancements are anticipated to drive further growth. For instance, in September 2020 Boston Scientific launched WaveWriter Alpha Spinal Cord Stimulator Systems for personalized pain relief.

Rising elderly population.

The consistently rising population of people above the age of 65 years is also expected to contribute to the pain management devices market growth. According to the United Nations (UN) data of World Population Prospects for the year 2019 highlighted that the world's population is expected to increase by two billion persons in the next 30 years, from 7.7 billion currently to 9.7 billion in 2050, and with this, the world's aging population is growing too. Due to increasing life expectancy and falling fertility levels, the UN explained that for the first time in history, individuals aged 65 or above outnumbered children under five years of age globally. Moreover, by 2050, one in six people in the world will be over the age of 65 (16%), up from one in 11 in 2019 (9%). Thus, with the increasing geriatric population, the demand for pain management devices is also expected to increase, considering the prevalence of arthritis in them.

COVID - 19 Impact on pain management devices market.

The COVID-19 outbreak affected most of the sectors including the medical device industry. Cross country lockdowns have affected patients who explicitly depended on practice projects or PT as a pain management routine. In addition, numerous elective systems, in-person persistent visits have been suspended or postponed, which is relied upon to build the interest for at-home pain treatment, thus expected to affect the pain management devices market growth.

Competitive Insights.

The increasing demand for pain management devices has led to the entry of several new market players like Pain Management Technologies in the pain management devices market. The entry of these new players in a market where traditional pharma behemoths like Abbott Laboratories and Boston Scientific Corporation already exist is expected to lead to further innovation in the pain management market. Moreover, in order to further increase their clientele as well as increase their market share in the upcoming years, many of these market players have taken various strategic actions like partnerships and the development of novel solutions which primarily focus on providing comfort to the patient. For instance, in June 2020, Abbott partnered with Tandem Diabetes Care to develop integrated diabetes solutions. These strategic actions by the various competitive market players are expected to keep the market competitive and constantly evolving.

Market Segmentation:

  • By Devices
  • Electrical Stimulators
  • Neurostimulation Devices
  • Analgesic Infusion Pumps
  • Ablation Devices
  • By Application
  • Facial & Migraine Pain
  • Neuropathic Pain
  • Cancer Pain
  • Musculoskeletal Pain
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • Italy
  • France
  • Others
  • Middle East and Africa
  • Israel
  • Saudi Arabia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Function
  • 4.4. Function Value Chain Analysis

5. Global Pain Management Devices Market Analysis, By Devices

  • 5.1. Introduction
  • 5.2. Electrical Stimulators
  • 5.3. Neurostimulation Devices
  • 5.4. Analgesic Infusion Pumps
  • 5.5. Ablation Devices

6. Global Pain Management Devices Market Analysis, By Application

  • 6.1. Introduction
  • 6.2. Facial & Migraine Pain
  • 6.3. Neuropathic Pain
  • 6.4. Cancer Pain
  • 6.5. Musculoskeletal Pain
  • 6.6. Others

7. Global Pain Management Devices Market Analysis, By Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. UK
    • 7.4.2. Germany
    • 7.4.3. Italy
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. The Middle East and Africa
    • 7.5.1. Israel
    • 7.5.2. Saudi Arabia
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. Japan
    • 7.6.3. India
    • 7.6.4. Australia
    • 7.6.5. South Korea
    • 7.6.6. Taiwan
    • 7.6.7. Thailand
    • 7.6.8. Indonesia
    • 7.6.9. Others

8. Competitive Environment and Analysis

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrativeness
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Vendor Competitiveness Matrix

9. Company Profiles.

  • 9.1. NeuroMetrix, Inc.
  • 9.2. Medtronic
  • 9.3. Boston Scientific Corporation
  • 9.4. Zynex Medical
  • 9.5. BioElectronics Corporation
  • 9.6. Pain Management Technologies
  • 9.7. SPR Therapeutics
  • 9.8. Becton, Dickinson, and Company
  • 9.9. Abbott
  • 9.10. Nevro Corp